SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- RayzeBio, Inc. (Nasdaq: RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today ...
Chemistry, manufacturing, and controls (CMC) is key in drug development, ensuring novel therapeutics’ consistency, quality, and safety. The approval process for new medications can take 10–15 years, ...
Two related decisions of a panel under the CIRA CDRP have considered the extent to which an individual’s name can serve as a basis for a successful complaint. On balance, the decision appears ...
A Canadian Internet Registration Authority panel has considered whether proceedings under the CIRA Domain Name Dispute Resolution Policy could be commenced and successful where the dispute involved a ...
SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers ...
Starting April 1, 2023, the U.S. Food and Drug Administration (FDA) will begin accepting requests to participate in a new Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results